Search Results for: CLINICAL TRIALS Its Time to

Articles

- 2/15/2011

BASF & Medi-Solve Coatings to Develop Multifunctional Coating Solutions for Medical Devices BASF Future Business GmbH and Medi-Solve Coatings LLC...

- 10/30/2012

Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...

- 1/31/2012

Amgen to Buy Micromet for $1.16 Billion Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger...

- 2/1/2011

Ligand Pharmaceuticals Forms Drug Development Alliance With Chiva PharmaceuticalsLigand Pharmaceuticals, Inc. recently announced it has entered into a strategic relationship...

- 1/24/2012

Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company,...

- ASSAY VALIDATION – Biomarker Assay Validations – A Time for Change?

John L. Allinson, FIBMS, believes despite the increased use of biomarkers, it appears that many researchers are still continuing to use the FDA guidance document for validation even though it only critically addresses the validation of assays to support PK evaluation, and also has a limited scope described within the document in terms of studies where it should be used.